Literature DB >> 23433723

The effectiveness of mutual support group intervention for Chinese families of people with schizophrenia: a randomised controlled trial with 24-month follow-up.

Wai Tong Chien1, Sally W C Chan.   

Abstract

BACKGROUND: Positive effects on the relapse from illness and compliance with medication by patients have been observed from family intervention for schizophrenia. However, little attention has been paid to the effects on family members, particularly those in non-Western countries. Inconsistent and inconclusive findings were found on the family-related outcomes and longer-term effects of family intervention.
OBJECTIVE: This study tested the effects of a nine-month family-led mutual support group for Chinese people with schizophrenia, compared with a psycho-education group and standard psychiatric care over a 24-month follow-up.
DESIGN: A randomised controlled trial [registered with ClinicalTrials.gov (NCT00940394)] with repeated-measures, three-group design. SETTINGS: Two regional psychiatric outpatient clinics in Hong Kong. PARTICIPANTS: One hundred and thirty-five Chinese family caregivers and their patients with schizophrenia were randomly recruited, of whom 45 family dyads received family-led mutual support group, a psycho-education group, or standard care.
METHODS: After completing the pre-test questionnaire, the participants were randomly assigned into one of the three study groups. The mutual support and psycho-education groups comprised 14 two-hour group sessions, with patients participating in at least 5 sessions. Those in standard care (and two treatment groups) received routine psychiatric care. Multiple patient and family-related psychosocial outcomes were compared at recruitment and at one week, 12 months, and 24 months following interventions.
RESULTS: One hundred and twenty-six of 135 family dyads completed the three post-tests and 43 (95.6%) attended at least nine group sessions (60%) of the mutual support group programme. Mean ages of the family caregivers in the study ranged from 41.2 (SD=7.0) to 42.7 (SD=7.6) years. About two-thirds of the caregivers were male and patients' parent or spouse. The results of multivariate analysis of variance followed by Helmert contrasts tests indicated that the participants in the mutual support group indicated significantly greater improvement in family and patient functioning [F(2, 132)=5.40, p=0.005 and F(2, 132)=6.88, p=0.001, respectively] and social support for families [F(2, 131)=5.01, p=0.005], and in reducing patients' symptom severity [F(2, 132)=4.65, p=0.01] and length of re-hospitalisations [F(2, 132)=4.78, p=0.01] at 12- and 24-month follow-ups.
CONCLUSIONS: Family-led mutual support group for schizophrenia produces longer-term benefits to both the patients' and families' functioning and relapse prevention for patients, compared with psycho-education and standard care. This group programme can be an effective family intervention for Chinese people with schizophrenia.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Family intervention; Mutual support group; Psychoeducation; Randomised controlled trial; Schizophrenia

Mesh:

Year:  2013        PMID: 23433723     DOI: 10.1016/j.ijnurstu.2013.01.004

Source DB:  PubMed          Journal:  Int J Nurs Stud        ISSN: 0020-7489            Impact factor:   5.837


  9 in total

1.  Effectiveness of Family Intervention for Preventing Relapse in First-Episode Psychosis Until 24 Months of Follow-up: A Systematic Review With Meta-analysis of Randomized Controlled Trials.

Authors:  Miguel Camacho-Gomez; Pere Castellvi
Journal:  Schizophr Bull       Date:  2020-01-04       Impact factor: 9.306

Review 2.  Needs of siblings of persons with psychosis: a systematic descriptive review.

Authors:  Anekal C Amaresha; Ganesan Venkatasubramanian; D Muralidhar
Journal:  Clin Psychopharmacol Neurosci       Date:  2014-08-12       Impact factor: 2.582

3.  Comprehensive family therapy: an effective approach for cognitive rehabilitation in schizophrenia.

Authors:  Jun Cai; Yi Zhu; Weibo Zhang; Yanfeng Wang; Chen Zhang
Journal:  Neuropsychiatr Dis Treat       Date:  2015-05-21       Impact factor: 2.570

4.  A randomized controlled trial of a mindfulness-based intervention program for people with schizophrenia: 6-month follow-up.

Authors:  Li-Qun Wang; Wai Tong Chien; Lai King Yip; Thanos Karatzias
Journal:  Neuropsychiatr Dis Treat       Date:  2016-12-07       Impact factor: 2.570

Review 5.  Do Family Interventions Improve Outcomes in Early Psychosis? A Systematic Review and Meta-Analysis.

Authors:  Melanie Claxton; Juliana Onwumere; Miriam Fornells-Ambrojo
Journal:  Front Psychol       Date:  2017-03-27

6.  Preferences for WeChat-Based and Hospital-Based Family Intervention Among Caregivers of People Living with Schizophrenia.

Authors:  Xiantao Zhang; Bibo Liu; Difan Zang; Yilu Li; Shuiyuan Xiao; Yu Yu
Journal:  Patient Prefer Adherence       Date:  2022-03-05       Impact factor: 2.711

7.  Relationships of Family Emotional Support and Negative Family Interactions with the Quality of Life among Chinese People with Mental Illness and the Mediating Effect of Internalized Stigma.

Authors:  Ching-Wen Chang; Fang-Pei Chen
Journal:  Psychiatr Q       Date:  2021-03

8.  Recommendations for the optimal care of patients with recent-onset psychosis in the Asia-Pacific region.

Authors:  Tak Lam Lo; Matthew Warden; Yanling He; Tianmei Si; Seshadri Kalyanasundaram; Manickam Thirunavukarasu; Nurmiati Amir; Ahmad Hatim; Tomas Bautista; Cheng Lee; Robin Emsley; Jose Olivares; Yen Kuang Yang; Ronnachai Kongsakon; David Castle
Journal:  Asia Pac Psychiatry       Date:  2016-06       Impact factor: 2.538

9.  A pilot, quasi-experimental, mixed methods investigation into the efficacy of a group psychotherapy intervention for caregivers of outpatients with cancer: the COPE study protocol.

Authors:  Rathi Mahendran; Joyce Yi Siang Tan; Konstadina Griva; Haikel Asyraf Lim; Hui Ying Ng; Joanne Chua; Siew Eng Lim; Ee Heok Kua
Journal:  BMJ Open       Date:  2015-11-19       Impact factor: 2.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.